William Campbell, PhD Named Eminent Scholar
Aug. 21, 2014 College News - William Campbell, PhD, Professor and Chair, Pharmacology & Toxicology, was awarded an Eminent Scholar designation at the July meeting of the Board of Trustees of the Medical College of Wisconsin.
The Eminent Scholar program recognizes and rewards excellence in academic and scholarly achievement that ordinarily would be funded from an endowed chair. The term of the funding is five years and is awarded to the faculty member, rather than the department. Funds are used to support academic and scholarly activities which can include lab expenses, travel to seminars or conferences, and/or funding a portion of the faculty awardee’s base compensation. One Eminent Scholar designation is awarded every year.
Dr. Campbell joined MCW in 1992. He has published more than 300 peer-reviewed papers and book chapters, and his lab has been continuously funded by the National Institutes of Health (NIH) for more than 35 years. He has earned prestigious honors, including the Novartis Award for Hypertension Research from the American Heart Association (AHA), the Paul Vanhoutte Award in Vascular Pharmacology from the American Society for Pharmacology and Experimental Therapeutics, and the Excellence in Pharmacology and Toxicology Award from the PhRMA Foundation. He was one of three recipients of the 2013 Distinguished Service Awards and is currently completing a sabbatical at the Magdalen College Oxford.
In short, Dr. Campbell continuously brings great international recognition to MCW by virtue of his more than 30 years of research into the regulation of arterial pressure by endogenous mediators – resulting in lasting and critical significance.